Project: microRNA tests for diagnosing preclinical Alzheimer’s disease and accelerating drug development

Acronym	proAD (Reference Number: 115456)
Duration	01/09/2021 - 01/09/2024
Project Topic	The project wants to deliver 1) a quick screening test for binary diagnosis of sporadic Alzheimer’s disease (sAD) in patients with subjective to mild cognitive impairment and for patient stratification in clinical trials, and 2) a quantitative test for confirming the binary diagnosis and for assessment of drug efficacy, kinetics, and treatment efficacy. After finishing the project, both tests will be commercially exploited for use a non-regulatory context and are ready for requesting CE approval
Network	Eurostars 2
Call	Eurostars Cut–off 15

Project partner

Number	Name	Role	Country
1	OPTOI SRL	Partner	Italy
2	ToxGenSolutions BV	Coordinator	Netherlands